Scientific Reports (Mar 2018)
Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging
- Yingji Jin,
- Yoshito Takeda,
- Yasushi Kondo,
- Lokesh P. Tripathi,
- Sujin Kang,
- Hikari Takeshita,
- Hanako Kuhara,
- Yohei Maeda,
- Masayoshi Higashiguchi,
- Kotaro Miyake,
- Osamu Morimura,
- Taro Koba,
- Yoshitomo Hayama,
- Shohei Koyama,
- Kaori Nakanishi,
- Takeo Iwasaki,
- Satoshi Tetsumoto,
- Kazuyuki Tsujino,
- Muneyoshi Kuroyama,
- Kota Iwahori,
- Haruhiko Hirata,
- Takayuki Takimoto,
- Mayumi Suzuki,
- Izumi Nagatomo,
- Ken Sugimoto,
- Yuta Fujii,
- Hiroshi Kida,
- Kenji Mizuguchi,
- Mari Ito,
- Takashi Kijima,
- Hiromi Rakugi,
- Eisuke Mekada,
- Isao Tachibana,
- Atsushi Kumanogoh
Affiliations
- Yingji Jin
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Yoshito Takeda
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Yasushi Kondo
- Sumitomo Dainippon Pharma Co., Ltd
- Lokesh P. Tripathi
- National Institute of Biomedical Innovation, Health and Nutrition
- Sujin Kang
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Hikari Takeshita
- Department of Geriatric Medicine &, Osaka University Graduate School of Medicine
- Hanako Kuhara
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Yohei Maeda
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Masayoshi Higashiguchi
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Kotaro Miyake
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Osamu Morimura
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Taro Koba
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Yoshitomo Hayama
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Shohei Koyama
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Kaori Nakanishi
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Takeo Iwasaki
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Satoshi Tetsumoto
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Kazuyuki Tsujino
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Muneyoshi Kuroyama
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Kota Iwahori
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Haruhiko Hirata
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Takayuki Takimoto
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Mayumi Suzuki
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Izumi Nagatomo
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Ken Sugimoto
- Department of Geriatric Medicine &, Osaka University Graduate School of Medicine
- Yuta Fujii
- Sumitomo Dainippon Pharma Co., Ltd
- Hiroshi Kida
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Kenji Mizuguchi
- National Institute of Biomedical Innovation, Health and Nutrition
- Mari Ito
- National Institute of Biomedical Innovation, Health and Nutrition
- Takashi Kijima
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Hiromi Rakugi
- Department of Geriatric Medicine &, Osaka University Graduate School of Medicine
- Eisuke Mekada
- Department of Cell Biology, Research Institute for Microbial Diseases, Osaka University
- Isao Tachibana
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- Atsushi Kumanogoh
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita
- DOI
- https://doi.org/10.1038/s41598-018-23338-x
- Journal volume & issue
-
Vol. 8,
no. 1
pp. 1 – 14
Abstract
Abstract Chronic obstructive pulmonary disease (COPD) has been recently characterized as a disease of accelerated lung aging, but the mechanism remains unclear. Tetraspanins have emerged as key players in malignancy and inflammatory diseases. Here, we found that CD9/CD81 double knockout (DKO) mice with a COPD-like phenotype progressively developed a syndrome resembling human aging, including cataracts, hair loss, and atrophy of various organs, including thymus, muscle, and testis, resulting in shorter survival than wild-type (WT) mice. Consistent with this, DNA microarray analysis of DKO mouse lungs revealed differential expression of genes involved in cell death, inflammation, and the sirtuin-1 (SIRT1) pathway. Accordingly, expression of SIRT1 was reduced in DKO mouse lungs. Importantly, siRNA knockdown of CD9 and CD81 in lung epithelial cells additively decreased SIRT1 and Foxo3a expression, but reciprocally upregulated the expression of p21 and p53, leading to reduced cell proliferation and elevated apoptosis. Furthermore, deletion of these tetraspanins increased the expression of pro-inflammatory genes and IL-8. Hence, CD9 and CD81 might coordinately prevent senescence and inflammation, partly by maintaining SIRT1 expression. Altogether, CD9/CD81 DKO mice represent a novel model for both COPD and accelerated senescence.